---
title: "Adaptive Biotechnologies director Michelle Renee Griffin disposes of 52,084 common shares worth $1,051,855.12"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291199942.md"
description: "Adaptive Biotechnologies director Michelle Renee Griffin sold 52,084 common shares on June 25, 2026, at $20.18 per share, totaling approximately $1.05 million. The sale followed the exercise of stock options at $7.80. Consequently, her direct holdings decreased to 15,625 shares."
datetime: "2026-06-29T23:50:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291199942.md)
  - [en](https://longbridge.com/en/news/291199942.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291199942.md)
---

# Adaptive Biotechnologies director Michelle Renee Griffin disposes of 52,084 common shares worth $1,051,855.12

-   Adaptive Biotechnologies director Michelle Renee Griffin sold 52,084 common shares on June 25, 2026 at USD 20.18. \* Sale followed the exercise of 52,084 stock options at USD 7.8 on the same day. \* Directly held common shares fell to 15,625. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001229765-26-000008), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ADPT.US](https://longbridge.com/en/quote/ADPT.US.md)

## Related News & Research

- [Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sells 3,000 shares for $75,000](https://longbridge.com/en/news/295720905.md)
- [576,266 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Wasatch Advisors LP](https://longbridge.com/en/news/295772850.md)
- [Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 1,299 common shares for $31,176](https://longbridge.com/en/news/294743960.md)
- [Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 million](https://longbridge.com/en/news/293677690.md)
- [Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 shares for $115,000](https://longbridge.com/en/news/293262025.md)